We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.14%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.97B
AUM Growth
-$688M
(-10%)
Cap. Flow
-$778M
Cap. Flow
% of AUM
-13.04%
Top 10 Holdings %
Top 10 Hldgs %
12.48%
Holding
1,150
New
217
Increased
235
Reduced
398
Closed
276
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$51.8M |
| 2 |
Visa
V
|
+$46.4M |
| 3 |
Comcast
CMCSA
|
+$45.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$36.3M |
| 5 |
Norfolk Southern
NSC
|
+$30.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$52.2M |
| 2 |
Starbucks
SBUX
|
+$51M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$41.7M |
| 4 |
Eli Lilly
LLY
|
+$40.3M |
| 5 |
Booking.com
BKNG
|
+$36.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.23% |
| 2 | Industrials | 13.43% |
| 3 | Financials | 12.16% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Healthcare | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMG
426
DELISTED
OM GROUP INC.
OMG
| $1.74M | 0.03% |
+52,375
| New | +$1.76M |
|
427
Cytokinetics
CYTK
$11B
| $1.73M | 0.03% |
182,100
+55,670
| +44% | +$504K |
|
428
LPL Financial
LPLA
$26.3B
| $1.7M | 0.03% |
32,360
-250
| -0.8% | -$13.2K |
|
429
Boise Cascade
BCC
$2.74B
| $1.69M | 0.03% |
59,110
-164,808
| -74% | -$4.88M |
|
430
United Parks & Resorts
PRKS
$2.11B
| $1.69M | 0.03% |
55,930
-49,450
| -47% | -$1.59M |
|
|
BHI
431
DELISTED
Baker Hughes
BHI
| $1.67M | 0.03% |
25,620
-430
| -2% | -$25.4K |
|
432
Charles River Laboratories
CRL
$10.9B
| $1.66M | 0.03% |
+27,470
| New | +$1.6M |
|
|
TXNM
433
TXNM Energy Inc
TXNM
$6.47B
| $1.65M | 0.03% |
61,200
-256,130
| -81% | -$6.48M |
|
434
Avient
AVNT
$3.45B
| $1.65M | 0.03% |
+44,930
| New | +$1.61M |
|
|
LPT
435
DELISTED
Liberty Property Trust
LPT
| $1.64M | 0.03% |
+44,320
| New | +$1.6M |
|
|
NAV
436
DELISTED
Navistar International
NAV
| $1.63M | 0.03% |
48,035
-163,609
| -77% | -$5.79M |
|
437
Colgate-Palmolive
CL
$72.6B
| $1.62M | 0.03% |
25,010
-248,040
| -91% | -$15.6M |
|
438
AMERISAFE
AMSF
$569M
| $1.62M | 0.03% |
36,806
+3,300
| +10% | +$138K |
|
439
Edison International
EIX
$30.7B
| $1.61M | 0.03% |
28,460
-38,940
| -58% | -$1.94M |
|
|
SHLM
440
DELISTED
Schulman (A.) Inc
SHLM
| $1.61M | 0.03% |
44,413
-800
| -2% | -$27.5K |
|
441
Arthur J. Gallagher & Co
AJG
$63.7B
| $1.59M | 0.03% |
+33,500
| New | +$1.56M |
|
|
RGC
442
DELISTED
Regal Entertainment Group
RGC
| $1.59M | 0.03% |
85,156
-24,200
| -22% | -$465K |
|
|
PRSU
443
Pursuit Attractions and Hospitality Inc
PRSU
$1.43B
| $1.59M | 0.03% |
66,050
-36,933
| -36% | -$910K |
|
444
Extreme Networks
EXTR
$3.86B
| $1.59M | 0.03% |
273,365
-1,115,214
| -80% | -$7.08M |
|
445
Accuray
ARAY
$28.4M
| $1.56M | 0.03% |
+162,676
| New | +$1.54M |
|
446
Exponent
EXPO
$2.98B
| $1.53M | 0.03% |
81,692
-10,000
| -11% | -$184K |
|
447
Sabra Healthcare REIT
SBRA
$5.64B
| $1.53M | 0.03% |
54,861
-75,330
| -58% | -$2.07M |
|
448
ArcBest
ARCB
$3.44B
| $1.5M | 0.03% |
+40,650
| New | +$1.39M |
|
|
MPT
449
Medical Properties Trust
MPT
$2.89B
| $1.5M | 0.03% |
+117,230
| New | +$1.51M |
|
|
ANN
450
DELISTED
ANN INC
ANN
| $1.49M | 0.02% |
35,880
-126,959
| -78% | -$4.53M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2014 Portfolio in Review
As of Q1 2014, Jacobs Levy Equity Management held 1,150 positions worth $5.97B, down 10% from $6.66B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management withdrew a net $778M in Q1 2014, closing 276 positions and reducing 398 holdings. Its most notable exit was Allergan Inc, an estimated $52.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bristol-Myers Squibb worth $35.5M.
- Jacobs Levy Equity Management's largest Q1 2014 buy was Bristol-Myers Squibb: 683,110 shares worth $35.5M.
- Jacobs Levy Equity Management added most to Amazon in Q1 2014, an estimated $51.8M increase.
- Jacobs Levy Equity Management's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $40.3M.
- Jacobs Levy Equity Management fully exited Allergan Inc in Q1 2014, selling an estimated $52.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.97B portfolio in Q1 2014.
- Jacobs Levy Equity Management opened 217 new positions and closed 276 in Q1 2014.
- Jacobs Levy Equity Management's portfolio value fell 10% quarter-over-quarter to $5.97B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2014, filed 15 May 2014.